आईएसएसएन: 2157-2518
टिप्पणी
Malignancy Genomics and Immuno-Oncological Markers to Control Insusceptible Treatments
Cancer Genomics Transformation and Treatment
Cancer Genomics: A New Perception in Cancer Prevention
छोटी समीक्षा
Presumptive Evidence for ADAR1 A-to-I Deamination at WA-sites as the Mutagenic Genomic Driver in Hepatocellular and Related ADAR1-Hi Cancers
Opportunities of Intersection for Cancer Genomics and Immunotherapy